TABLE VII.
Patient averaged ROR values using LAR values relative to PPT with four fields. PPT: passive proton beam therapy; PBS: proton beam scanning; PvP: risk after a proton treatment divided by the risk after a photon treatment.
| Bone sarcoma | Brain carcinoma | Brain sarcoma | ||||
|---|---|---|---|---|---|---|
| Modality | ROR | ΔROR/ROR (%) | ROR | ΔROR/ROR (%) | ROR | ΔROR/ROR (%) |
| IMRT, 5 field | 3.84 | 9.6 | 1.58 | 1.1 | 1.71 | 0.7 |
| IMRT, 7 field | 3.62 | 8.7 | 1.59 | 1 | 1.69 | 0.8 |
| VMAT | 3.18 | 8.2 | 1.61 | 1.2 | 1.68 | 0.8 |
| PPT, 3 field | 1.21 | 4.6 | 0.89 | 3.1 | 1.09 | 0.9 |
| PPT, 4 field | 1 | — | 1 | — | 1 | — |
| PBS, 3 field, 10 mm | 0.86 | 5 | 0.76 | 2.2 | 0.88 | 1.5 |
| PvP | 0.35 | 5.1 | 0.56 | 1.7 | 0.59 | 1.4 |